Pyridoxal Phosphate

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO DeficiencyNCT04706013MedicurePhase 3Active not recruiting2027-09Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.